Translumina Therapeutics Private Limited

Founded in January 2025 and headquartered in Delhi, India.

2025 | New Delhi, Delhi (India) | Active
Last Updated:

Translumina Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Months 17 Days
  • Open Charges ₹ 201.55 Cr
  • Satisfied Charges ₹ 9.65 Cr

About Translumina Therapeutics

Translumina Therapeutics Private Limited (TTPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2025 ( three months 17 days old ). Its registered office is in New Delhi, Delhi.

The Company's status is Active It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹201.55 Cr. The company has closed loans amounting to ₹9.65 Cr, as per Ministry of Corporate Affairs (MCA) records.

Punita Sharma, Vishal Sharma, Indranil Mukherjee, and One other member serve as directors at the Company.

Company Details

  • Location New Delhi, Delhi
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U32509DL2025PTC441712

  • Company No.

    441712

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    25 Jan 2025

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Company report

Translumina Therapeutics Private Limited

Explore comprehensive data for Translumina Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Translumina Therapeutics?

Board Members (4)

NameDesignationAppointment DateStatus
Vishal Sharma Country flag representing In Nominee Director 25-Jan-2025Current
Punita Sharma Country flag representing In Nominee Director 25-Jan-2025Current
Indranil Mukherjee Country flag representing In Nominee Director 25-Jan-2025Current
Vishal Goenka Country flag representing In Nominee Director 25-Jan-2025Current

Financial Performance of Translumina Therapeutics.

Translumina Therapeutics revenue growth over time
Translumina Therapeutics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Translumina Therapeutics?

Unlock access to Translumina Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹201.55 Cr

Satisfied Charges

₹9.65 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 140.55 Cr
  • Citi Bank N.A : 50.00 Cr
  • Icici Bank Limited : 11.00 Cr

Latest Charge Details

DateLenderAmountStatus
12 Jun 2023Citi Bank N.A₹50.00 CrOpen
18 Nov 2022Hdfc Bank Limited₹2.30 MOpen
30 Aug 2022Icici Bank Limited₹11.00 CrOpen
20 Apr 2022Hdfc Bank Limited₹1.61 MOpen
28 Jan 2022Hdfc Bank Limited₹140.00 CrOpen

How Many Employees Work at Translumina Therapeutics?

Unlock and access historical data on people associated with Translumina Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Translumina Therapeutics Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Translumina Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Translumina Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Translumina Therapeutics

Recent activity within the organization

  • Director Appointment

    Punita Sharma was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jan 2025 & has been associated with this company since 3 months 17 days .

  • Director Appointment

    Vishal Sharma was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jan 2025 & has been associated with this company since 3 months 17 days .

  • Director Appointment

    Indranil Mukherjee was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jan 2025 & has been associated with this company since 3 months 17 days .

  • Director Appointment

    Vishal Omprakash Goenka was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jan 2025 & has been associated with this company since 3 months 17 days .

  • Charges

    A charge registered on 14 Jun 2019 via Charge ID 100272202 with Axis Bank Limited was fully satisfied on 07 Jan 2025.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 140.00 Cr registered on 28 Jan 2022 with Charge ID 100534152 was modified on 14 Jun 2024.

Frequently asked questions

  • What is the Incorporation or founding date of Translumina Therapeutics Private Limited?

    Translumina Therapeutics Private Limited was incorporated on 25 Jan 2025.

  • What is authorized share capital and paid-up capital of Translumina Therapeutics Private Limited?

    The authorized share capital of Translumina Therapeutics Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Translumina Therapeutics Private Limited?

    Currently 4 directors are associated with Translumina Therapeutics Private Limited.

    • Punita Sharma
    • Vishal Sharma
    • Indranil Mukherjee
    • Vishal Omprakash Goenka
  • What is the registered address of Translumina Therapeutics Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Translumina Therapeutics Private Limited is Plot No. 1 Ground Floor Lsc M.O.R Land India, New Delhi, 110060.

  • What is the corporate identification number (CIN) and company number of Translumina Therapeutics Private Limited?

    The corporate identification number (CIN) of Translumina Therapeutics Private Limited is U32509DL2025PTC441712 and the company number is 441712 as per Ministry of Corporate Affairs (MCA).

  • What are the total open charges for Translumina Therapeutics Private Limited?

    As per the financial statements for fiscal Year , The total open charges for Translumina Therapeutics Private Limited amount to ₹ 201.55 Cr.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial